Skip to main content
Premium Trial:

Request an Annual Quote

Organon to Use BioImage Assay Technology for Compound Profiling

NEW YORK, Sept. 7 (GenomeWeb News) - Danish biotechnology company BioImage announced today that it has signed a research agreement with Organon to profile selected lead compounds using BioImage's cell-based assay technology.


Under the terms of the agreement, Organon will utilize a series of BioImage's Redistribution assays to perform pathway profiling on selected lead compounds produced at Organon's research and development facilities in Oss, the Netherlands.


Financial terms of the agreement were not disclosed.